INTRODUCTION
Ginseng has been used for at least 2000 years in China and other Asian countries to support vitality and a long life. In traditional Chinese medicine it is often described as a 'precious tonic' that stimulates natural resistance to infection and maintains homeostasis (Hanley et al., 2012a; Kumagai et al., 2013) . It is typically extracted from the roots of Panax ginseng C Mayer (Asian) and Panax quinfolious (American) and contains a complex mixture of bioactive compounds; the most extensively studied being the 'steroid-like' dammarane triterpenoid glycosides, termed ginsenosides. Ginsenosides are further subdivided into protopanaxdiols (PPD) (examples shown in Figure 1 ) or protopanaxtriols (PPT) depending on the location of the sugar moieties on the dammarane carbon skeleton. Both glycosylated classes may have sugar moieties on carbon (C) 20 but protopanaxadiols can have additional sugar moieties on C-3 whereas protopanaxatriols are on C-6. The aglycones of both classes differ only in the presence of an extra hydroxyl group on C-6 in the triol (Tomasinsig et al., 2008; Chotjumlong et al., 2013) . Ginseng is commercially available in a variety of forms (capsules, tablets, oils) where the type and amounts of constituent ginsenosides are precisely controlled. The G115 formulation tested in this study contains 4% w/w ginsenosides and is a principle constituent of Ginsana® and Gincosan® medications (Ginsana SA).
We are interested in understanding the mechanisms underlying the reported immunomodulatory effects of ginseng/ginsenosides as they may translate into effective medications for the prevention and treatment of infective and inflammatory diseases. In vivo studies using ginseng formulations have been shown to protect against lung infections caused by Pseudomonas Aeruginosa improving pulmonary bacterial clearance (Song et al., 1997a; Song et al., 1997b; Song et al., 2010) and a clinical trial demonstrated a significant reduction in the number of cases of influenza when given as an adjuvant with vaccine that correlated with increased antibody titres and NK cell activity (Scaglione et al., 1996) . Similar adjuvant effects have also been consistently demonstrated with ginsenosides in vivo (Rivera et al., 2005; Han et al., 2013) . In vitro, ginsenosides have been shown to either trigger or prevent apoptosis depending on cell type or the specific ginsenoside used (Ham et al., 2006; Zhang et al., 2008; Li et al., 2012; Zhang et al., 2013; Zheng et al., 2014) . A number of studies have also demonstrated that ginsenosides can act via either genomic Eβ or glutocorticoid receptors in the sub-micromolar range to differentially regulate angiogenesis in endothelial cells (Sengupta et al., 2004; Leung et al., 2006; Leung et al., 2007; Leung et al., 2009) . However, similar to some endogenous steroids, ginsenosides have also been shown to rapidly and reversibly interact with ligand gated ion channels which points to additional non-genomic sites of action (Nah, 2014) . These include both inhibitory actions on nicotinic acetylcholine receptors (Lee et al., 2003) , 5-HT 3 receptors (Choi et al., 2003a) , NMDA receptors (Kim et al., 2002) , GABA A receptors (Lee et al., 2012) , TRPV1 channels (Huang et al., 2012) and potentiating actions on glycine (Noh et al., 2003) , GABA A receptors (Choi et al., 2003b) , and TRPV1 channels (Jung et al., 2001) .
In this study we tested the effects of ginsenosides on a subtype of ATP-gated ion channels of the P2X family, P2X7 receptors, given their important role in regulating immune cell function (Bartlett et al., 2014) . Studies have demonstrated P2X7 to play a role in Ca 2+ signalling, reactive oxygen species generation and cell death pathways and regulation of such signalling pathways may control immune responses (Bartlett et al., 2014) . We report that several glycosylated PPD ginsenosides, but not PPT ginsenosides, appear to be positive allosteric modulators of the ATP activated P2X7 channel which can lead to enhanced Ca 2+ influx and subsequent apoptosis in macrophages. Due to the relatively high expression levels of P2X7 in immune cells, this action may account for some of the reported immune modulatory actions of PPD ginsenosides in vivo.
MATERIALS AND METHODS

Materials
The P2X7 agonists ATP and BzATP were obtained from Sigma Aldrich (Ryde, NSW Australia).
P2X7 antagonists AZ-10606120 and A-438079 hydrochloride were obtained from Tocris Biosciences (Bristol, UK). ATP was prepared as a 100 mM stock in double distilled water, pH to 7.4 with NaOH and was stored at -80 °C until the day of experiment. AZ-10606120 and A-438079
(10 mM in DMSO) were stored at -20 °C. Ginsenosides (certified as 98 % pure) were obtained from and Shanghai E Star Bio Technology Co Ltd (Rh1, Rh2). Each compound was prepared as a 50 mM stock in DMSO and stored at -80 °C until the day of the experiment. All ginsenoside stocks were further diluted in DMSO to 1000X final concentration so that when diluted in assay buffers the final concentration of DMSO was 0.1%.
Cell Culture
HEK-293 cells stably transfected with the human P2X7 (standard nomenclature conforms to guidelines (Alexander et al., 2013) ) plasmid (clone pJB3) were maintained in DMEM:F12 media (Life Technologies catalogue number 11320-033) supplemented with 10% foetal bovine serum (FBS, French origin, Bovogen, Australia), 1% Glutamax, 10 000 U. ml -1 penicillin and 10 mg. ml -1 streptomycin with selection under 400 µg. mL -1 G418 (Life Technologies). The J774 murine macrophage cell line was maintained in RPMI 1640 media supplemented with 10% FBS, 1%
Glutamax, and 1% penicillin and streptomycin (Bhaskaracharya et al., 2014) .
Animals
Animal care and procedures were performed with permission of the local RMIT Animal Ethics Committee (approval number AEC1312) and in accordance with Australian guidelines for the use of animals. All studies involving animals are reported in accordance with the ARRIVE guidelines (Kilkenny et al., 2010) . Adult male C57BL/6 mice were maintained in a 12h light/dark cycle and fed standard diet with water ad libitum. Mice were killed by CO 2 asphyxiation and peritoneal macrophages were obtained by flushing the peritoneal cavity with cold PBS (5 ml).
Dye uptake experiments
Cells were plated at 2.5 x 10 4 cells per well the day before experiments into poly-D-lysine coated 96-well plates (ThermoFisher). YOPRO-1 iodide (Life Technologies) was used as the membrane impermeant dye with a final concentration of 2 µM in low divalent buffer (145 mM NaCl, 5 mM KCl, 0.2 mM CaCl 2 , 13 mM glucose, 10 mM HEPES, pH 7.3, osm 300-310). A Flexstation III plate reader (Molecular Devices) was used to acquire data using the following settings -excitation wavelength 490 nm, emission wavelength 520 nm and 6 reads per well. Data was analysed as slope of dye uptake or area under curve between 40 and 300 seconds using SoftMax Pro software (Molecular Devices). ATP and drugs were applied using a computer controlled fast-flow system (Bio-Logic Instruments, Claix, France) with the perfusion capillaries placed in close proximity to the cell under investigation.
Calcium measurements
Cell viability assays
Cells were plated at a density of 5 x 10 4 cells/well (50 µl) in a 96 well plate (Costar) in triplicate.
Compounds (or vehicle control) were added to the plate at 2X final concentration and cells were treated for 24 hours. Cell viability was assessed using the CellTiter Glo Aqueous One solution (Promega) which was added to the wells for the last 4 hours of the experiment. Absorbance was read at 490 nm using a BMG Labtech Clariostar plate reader.
Data plot and statistical analysis
Graphs were plotted using GraphPad Prism version 6 (La Jolla, USA). Concentration-response curves were fitted using a log (agonist) vs response -variable slope (four parameter) best-fit equation. Data was analysed for statistical significance using either unpaired t-tests or one-way ANOVA with post-tests as appropriate. Significance was taken as P<0.05.
RESULTS
Ginsenosides increase the rate of dye uptake through activated P2X7
To establish any potential effects of ginseng on P2X7 we used a standard screening assay that relies upon the uptake of the membrane impermeant dye YOPRO-1 iodide through the P2X7-dependent permeability pathway activated with the agonist ATP (Jursik et al., 2007; Bhaskaracharya et al., 2014) . The initial screening of compounds used an approximate EC 50 concentration of ATP (200 µM) in order to see either potentiation or inhibition of the response. We first tested a standard formulation of ginseng known as G115 since it is one of the main formulations used in the clinic.
Pre-treatment of HEK cells expressing human P2X7 (HEK-hP2X7) for 10 minutes with 100 µg.ml
G115 enhanced the rate of ATP-induced dye uptake by around 2-fold ( Figure 1A , B red trace).
G115 alone did not induce dye uptake in HEK-hP2X7 cells (Supplementary Figure 1) suggesting this was not due to a non-specific effect on the cells.
G115 contains a fixed amount (4% w/w) of eight ginsenosides from both PPD and PPT chemical classes, namely Rb1, Rc, Rd, Re (PPD ginsenosides) and Rb2, Rf, Rg1, Rg2 (PPT ginsenosides). It was important to establish whether the observed effects with G115 resulted from one or more specific ginsenoside(s) in the formulation. We tested 14 purified ginsenosides in a screening assay encompassing the eight ginsenosides in G115 plus the principle intestinal metabolites Rh1, Rh2, Rg3, compound K (CK) and the two aglycones PPD and PPT. All ginsenosides were tested at a concentration of 10 µM and were added 10 minutes prior to the addition of ATP (200 µM). None of the ginsenosides directly stimulated dye uptake (Supplementary Figure 1) however, four PPD ginsenosides, Rb1, Rd, Rh2 and CK, significantly increased the rate of dye uptake after ATP addition ( Figure 1C ). In contrast, ginsenosides of the PPT series (labelled green in Figure 1C ) had no significant effect on the ATP-induced dye uptake.
The chemical structures of the four ginsenosides with effect on P2X7 are shown in Figure 1D .
A glucopyranoside sugar residue in CK is essential for rapid P2X7 potentiation
Since the PPD aglycone was ineffective in potentiating P2X7 responses at concentrations up to 50
µM (data not shown) there is an absolute requirement for at least one sugar residue in this structure.
Based on our data this could be located at C-3 (Rh2) or C-20 (CK). As CK appeared to be the most potent in this assay and is one of the principle metabolites of ginseng reaching plasma concentrations of around 70 ng.ml -1 in humans (Kim et al., 2013) we focused our investigation on this ginsenoside to examine the potentiating action on P2X7 in more detail.
The potentiation of ATP responses at P2X7 by CK was also demonstrated in buffer containing physiological divalent ion concentrations (2 mM Ca 2+ , 1 mM Mg 2+ ). Under these conditions much higher concentrations of ATP (>500 µM) are required to elicit any significant dye uptake most likely due to the actions of these divalent ions in blocking P2X7 responses (Virginio et al., 1997) . CK could potentiate both 0.5 mM and 3 mM ATP responses ( Figure 2A ). The onset of potentiation of P2X7 responses by CK was rapid with immediate effects observed following coinjection of a pre-mixed cocktail of the agonist ATP and CK ( Figure 2B ). The response induced by ATP and CK was solely dependent on P2X7 as it could be completely abolished by pre-treatment with either of two selective P2X7 antagonists; AZ10606120 (10 µM) and A-438079 (10 µM) ( Figure 2C ).
Our initial experiments suggested that CK was not a direct activator or agonist of P2X7 since CK could not directly stimulate dye uptake in HEK-hP2X7 cells ( Supplementary Fig 1) . The EC 50 value of the potentiation effect of CK on hP2X7 was calculated as 1.08 µM (95% CI 0.86 µM to 1.35 µM) ( Figure 3A ). In contrast the aglycone PPD was ineffective at all concentrations tested (0.1 -50 µM). To determine if CK was acting as a positive allosteric modulator of P2X7 we performed a full concentration-response curve for ATP in the absence and presence of 10 µM CK ( Figure 3B ). Potentiation by CK left-shifted the concentration-response curve reducing the EC 50 from 244 µM to 71 µM, increased the maximum ATP response, and required a threshold concentration of ATP (~50 µM), In contrast when BzATP was used as a full agonist at human P2X7 (Surprenant et al., 1996) , CK did not increase the maximum response but did cause a leftshift in EC 50 from 19 µM to 4.4 µM ( Figure 3B ). Both leftward shifts were statistically significant (P<0.01).
Ginsenoside CK increases sustained calcium influx through P2X7
Due to their high permeability to calcium, P2X7 activation can result in a sustained rise in intracellular Ca 2+ leading to either proliferation/activation or cell death, depending on the magnitude and extent of channel activation (Adinolfi et al., 2005b) . Therefore it was important to establish whether the ginsenoside potentiation of P2X7 responses observed in dye uptake experiments lead to physiologically relevant sustained increases in intracellular Ca 2+ concentration. We first 
Ginsenosides are potent modulators of ATP-evoked P2X7 currents
To definitively demonstrate that PPD ginsenosides enhanced ionic flux through activated P2X7 channels we used the whole-cell patch-clamp technique and delivery of ATP -/+ ginsenosides via PPT ginsenosides had no effect at 50 µM, the highest concentration tested. The rank order of potency was CK > Rd >Rb1 with thresholds for effect around 50 nM, 0.5 µM and 10 µM respectively. These effects were rapid in onset occurring in <1 second of switching from ATP alone to ATP plus ginsenoside. Similarly the effects were rapidly reversible on wash-out of the ginsenoside in the continued presence of ATP. Consistent with the dye uptake data, the most potent ginsenoside CK did not directly activate P2X7 channels, only after prior activation with ATP (data not shown). The magnitude of potentiation was quantified by dividing the current amplitude after 5 seconds in ATP + ginsenoside by the amplitude in ATP alone immediately prior to ginsenoside addition ( Figure 5E ). Although all the PPD ginsenosides had a dose-dependent effect in regard to potentiating ATP evoked currents, it was not possible to demonstrate a maximal effect where further increases in ginsenoside concentration lead to no further increases in the potentiation. This was due to the fact that at higher concentrations of PPD ginsenosides the potentiating effect was so large that the cells could not be effectively voltage-clamped.
Given the rapid onset and reversibility of the potentiation it was likely that the site of interaction with P2X7 was extracellular. This was confirmed by comparing the amplitude of P2X7 currents evoked by 5 second pulses of 200 µM ATP in HEK-hP2X7 dialysed with standard pipette solution or pipette solution containing 1 µM CK for 5 minutes ( Figure 6A ). In both groups the amplitude of successive P2X7 currents (2 min apart) evoked by external ATP was similar; 221 ± 59 pA (n= 8) and 264 ± 48 pA (n=3) respectively (P>0.05, unpaired t -test). To confirm that the HEKhP2X7 cells containing intracellular CK pipette solution were still responsive to extracellular CK, compared to a fifth successive pulse of ATP alone in the control group. The ATP-evoked current in the presence of CK was 1953 ± 552 pA (n = 3), significantly larger than after ATP alone, 261 ± 82 pA (n =6 cells, P<0.05, unpaired t-test).
To confirm that the CK potentiation of the ATP activated current was solely mediated by P2X7 channels we first applied 200 µM ATP for 5 seconds followed by a 5 second addition of CK in the continued presence of ATP ( Figure 6B ). This resulted in a marked potentiation of the current that was almost completely and irreversibly blocked by a subsequent addition of the selective P2X7
antagonist AZ10606120 (10 µM; 92.6 ± 2% inhibition, n=4 cells) in the continued presence of CK and ATP ( Figure 6B ).
Ginsenoside CK does not induce an immediate permeability shift to large cations
The fact that PPD ginsenosides accelerated YO-PRO dye uptake in the presence of ATP might suggest that an underlying increase in the permeability of P2X7 channels to large molecular weight cations is associated with the potentiating action of ginsenosides. To investigate this possibility cells were bathed in a solution that contained NMDG as the only extracellular cation and dialysed with standard 145 mM NaCl-containing internal solution. Under these conditions, we applied 500 msec voltage ramps from -100 mV to +50 mV every 1 second. Fast application of ATP for 10 seconds evoked outward currents at all voltages positive to around -80 mV. The mean reversal potential (E rev ) at the end of the 10s ATP addition (Figure 7 , black bar) was -81 ± 2.1 mV (n=4 cells) and the mean outward current amplitude at -30 mV was 1186 ± 416 pA. Solution containing ATP and 1 µM CK was then applied (Figure 7 , hatched bar) which resulted in marked increase in the amplitude of the current at -30 mV within 2-3 seconds of addition (mean amplitude was 3667 ± 1017 pA). Hence under these conditions CK potentiated the amplitude of the outward current by around 3-fold but this was not associated with any measurable change in permeability (E rev -81.3 ± 2.4 mV). This is illustrated in Figure 7 (inset) where representative ramps in one cell are shown at the end of the first 10s addition of ATP (ATP Ramp) and 2-3s after the subsequent addition of ATP + 1 µM CK (ATP + CK Ramp). In the continued presence of ATP + 1 µM CK there was a progressive positive shift in E rev which reached -74 ± 2 mV by the end of the 10s addition ( Figure   7 ). These data suggest that permeability changes do not contribute to the fast potentiation of the P2X7-mediated current after CK addition.
Potentiation of P2X7 by ginsenoside CK is not dependent on cations or membrane voltage
We further used patch clamp recordings of HEK-hP2X7 cells to determine whether the presence of extracellular divalent cations (Ca 2+ , Mg 2+ ) could interact with potentiation of the ATP response.
The degree of potentiation of ATP-evoked inward currents was similar in standard extracellular solution (2 mM Ca 2+ ) although a higher concentration of ATP was required; 1 mM rather than 200 µM in 0.2 mM external Ca 2+ solution ( Figure 8A ). There was no voltage-dependence to the effect of CK as demonstrated by linear I-V relationships for ATP or ATP in the presence of CK ( Figure   8B ).
Ginsenoside CK potentiates endogenous P2X7 responses in mouse macrophages
We next established whether similar effects of the ginsenoside CK on endogenous P2X7 could be demonstrated in mouse macrophages. We determined that CK could potentiate mouse P2X7 Figure 9C ).
Finally, we investigated whether this potentiation of ATP-induced responses could translate to a significant downstream functional effect such as induction of apoptotic cell death. We used J774 macrophages and treated them with either CK alone (10 µM) or a non-lethal concentration of ATP (500 µM) for 24 hours. We determined any effect on cellular viability through an MTS viability assay. Neither 10 µM CK, DMSO or 500 µM ATP alone induced any detrimental effect on cell viability (n=4 experiments; Figure 10 ). In contrast, a high concentration of ATP (3 mM) for 24
hours could induce marked cell death resulting in a significant reduction of cell viability (to 16.7 ± 4.3 % of control, n=4). Treating J774 macrophages with a combination of 10 µM CK and previously non-lethal ATP (500 µM) together could also significantly reduce cell viability to 49.6 ± 11.3 % of control ( Figure 10B ).
DISCUSSION
In this study we have shown that certain ginsenosides (Rb1, Rh2, Rd and CK) markedly enhance P2X7 responses after prior activation with exogenous ATP. These effects were only manifest after previous P2X7 activation by orthostatic agonists (ATP, BzATP) and were first characterized in a HEK cell line expressing P2X7 and corroborated in a macrophage cell line (J774) and mouse peritoneal macrophages. The consequences of the interaction were increased Ca 2+ influx and a subsequent decrease in cell viability to lower concentrations of ATP. Given the widespread distribution of P2X7 channels on immune cells and the fact that effects could be observed in the sub-micromolar range with one of the principle metabolites of ginseng CK, it is possible that this mechanism may account for some of the reported immune modulatory actions of ginseng in vivo.
Since the potentiation of P2X7 responses appears to be unique to glycosylated PPD ginsenosides and can be observed in the low to sub-micromolar range (EC 50 of 0.45 -1.08 µM), it is unlikely to be a non-specific interaction resulting from changes in membrane fluidity as has been suggested for certain ginsenoside actions reflecting the amphipathic nature of these steroid-like saponins (Attele et al., 1999) . In addition, the site of action is likely to be extracellular and may involve a direct interaction with the P2X7 channel since effects are not observed with intracellular application of CK (1 µM). The potentiation is rapid in onset and is rapidly reversible. However, the kinetics of onset/reversibility were not specifically addressed in this study but are at least within 1 second based on our patch clamp experiments using a 'fast' drug application system.
The potentiating effects of PPD ginsenosides on P2X7 are novel for this family of ligandgated ion channels but do show some similarities to reported effects of ginsenosides on GABA A (Choi et al., 2003b) and glycine currents (Noh et al., 2003) in Xenopus oocytes. Although the concentrations of ginsenosides necessary for the observed effects were much higher on GABA and glycine channels (around 50 µM), these studies also indicated that PPD ginsenosides were more potent than PPT ginsenosides. Such studies of effects of ginsenosides on ion channels have been extensively reviewed in (Nah 2014). One PPD ginsenoside, Rg3, was additionally found to directly activate GABA channels containing the γ2 subunit (Lee et al., 2013) . In our study we demonstrate that the aglycone compounds PPD and PPT were ineffective at potentiating P2X7 which points to an absolute requirement of at least one sugar residue in PPD ginsenosides. Interestingly both PPD and PPT alglycones have been shown to inhibit rather than potentiate GABA A currents (Lee et al., 2012) . However, we did not observe any inhibitory effects on P2X7 responses with any ginsenoside compound. Further investigations are required to determine if there are any shared structural features between the ginsenoside binding sites on P2X7 and GABA A channels. This may also apply to HERG channels as it has been reported that PPD ginsenosides were typically more effective than PPT ginsenosides in potentiating tail currents and PPT/PPD aglycones were ineffective (Choi et al., 2011) .
Glycosylated PPD ginsenosides, such as the principal ginseng metabolite CK, are novel potent positive allosteric modulators of human P2X7. Several other positive modulators of P2X7 have been described including clemastine, tenidap, polymixin B, and ivermectin (Sanz et al., 1998; Ferrari et al., 2004; Norenberg et al., 2011; Nörenberg et al., 2012) . There are some similarities between the action of clemastine and CK on P2X7 channels in that their action is rapid (< 100ms), reversible, calcium-and voltage-independent, and uses an extracellular site. Similar to CK, modulators such as clemastine have no direct effects on P2X7 channels and required the presence of the agonist (Norenberg et al., 2011) . Although Norenberg et al reported an accelerated change in reversal potential occurring over tens of seconds, reflecting an increased rate in the permeability to NMDG + in the presence of ATP, they recognized that this cannot account for the rapid (<1 s) potentiating effect and reversibility of clemastine (Norenberg et al., 2011) . The most plausible explanation, which may also be applicable to PPD ginsenosides, is that such modulators increase
the mean-open time of P2X7 channels. Furthermore, such a net increase in channel activation is known to accelerate pore dilation. Hence this hypothesis may reconcile our patch data which clearly indicates that the rapid/reversible effects of ginsenosides are not associated with significant changes in permeability and our YOPRO data where ginsenosides clearly increase the rate of dye uptake.
An important consequence of the PPD ginsenoside action on P2X7 channels is enhanced sustained Ca 2+ influx in both macrophages and HEK cells stably expressing human P2X7. The use of CK as a positive allosteric modulator of P2X7 reduces the concentration of ATP required to generate a sustained Ca 2+ response (Figures 4, 8) . Many downstream consequences of P2X7 activation have been demonstrated to depend on sustained Ca 2+ signaling (Bartlett et al., 2014) .
With regard to cell viability, brief additions of high concentrations of ATP (<5 min, >1 mM) can lead to a transient ' pseudoapoptosis' that does not lead to cell death (Mackenzie et al., 2005) or a delayed cell death occurring after a number of hours (Hanley et al., 2012b) . Higher concentrations of ATP and /or prolonged applications on the other hand lead to cell death within minutes due to massive Ca 2+ influx (Mackenzie et al., 2005) . In contrast, lower concentrations of ATP (<1 mM) can have the opposite effect, stimulating proliferation and prolonging cell survival (Adinolfi et al., 2005a) . Consistent with this we have shown that enhancing Ca 2+ influx via P2X7 in macrophages through the use of CK can effectively convert a sub-lethal dose of 500 µM ATP into a lethal concentration as measured by a significant decrease in cell viability after 24h (Figure 10 ). However given the fact that the timing and extent of Ca 2+ influx via P2X7 can lead to different functional outcomes further studies are warranted with different ATP/PPD ginsenoside combinations and examination of other parameters in addition to cell viability.
In conclusion, the present study identifies selected ginsenosides as novel positive allosteric modulators of P2X7 channels. Our findings together suggest that the modulation of P2X7 may account for some of the reported immune modulatory actions of protopanaxdiol ginsenosides in vivo.
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Transient P2X7 receptor activation triggers macrophage death independent of Toll-like receptors 2 and 4, caspase-1, and pannexin-1 proteins. J Biol Chem 287 (13) (A) ATP-induced dye uptake was measured at 37 °C using YOPRO-1 (2 µM) as the membrane impermeant dye. Relative Fluorescence Units (RFU) were measured following excitation at 490 nm and emission recorded at 520 nm using a fluorescent plate reader (Flexstation III). HEK-hP2X7 cells were pre-treated with 10 or 100 µg. ml -1 G115 in a low divalent buffer for 10 minutes at 37 °C.
ATP ( (A) Cells were bathed in NMDG + external solution and a similar drug addition protocol to that in Figure 5A , using 1 µM CK (drugs applied for 10s rather than 5s). Voltage ramps (500ms) were applied from -100 mV to +50 mV every second throughout the experiment. Typical leak - (A) ATP-induced dye uptake was measured at 37 °C using YOPRO-1 (2 ?M) as the membrane impermeant dye. Relative Fluorescence Units (RFU) were measured following excitation at 490 nm and emission recorded at 520 nm using a fluorescent plate reader (Flexstation III). HEK293 cells stably expressing mouse P2X7 cells were pre-treated with 10 ?M CK in a low divalent buffer for 10 minutes at 37 °C. ATP (500 ?M) was then injected to elicit a P2X7 response. The mean of 6-10 individual wells is plotted from three independent experiments. (B) A concentration-response curve for CK potentiation on mouse P2X7. Data is mean of 6 wells for each concentration.
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